The Journal of Urology
Volume 180, Issue 5 , Pages 2005-2010 , November 2008

Radiation Therapy for Prostate Cancer Increases Subsequent Risk of Bladder and Rectal Cancer: A Population Based Cohort Study

  • Alan M. Nieder

      Affiliations

    • Department of Urology, University of Miami Miller School of Medicine, Miami, Florida
    • Corresponding Author InformationCorrespondence: Columbia University, Division of Urology, Mount Sinai Medical Center, 4306 Alton Rd., Suite 3014, Miami Beach, Florida 33140 (telephone: 305-674-2499; FAX: 305-674-2899)
    • ,
  • Michael P. Porter

      Affiliations

    • Departments of Urology & Epidemiology, University of Washington and the VA Puget Sound Health Care System, Seattle, Washington
    • ,
  • Mark S. Soloway

      Affiliations

    • Department of Urology, University of Miami Miller School of Medicine, Miami, Florida

Received 25 February 2008

References 

  1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43
  2. Ries LAG, Melbert D, Krapcho M, Mariotto A, Miller BA, Feuer EJ et al: SEER Cancer Statistics Review, 1975–2004. Bethesda, Maryland: National Cancer Institute, www.seer.cancer.gov/csr/1975_2004, based on November 2006 SEER data submission, posted to the SEER web site 2007.
  3. Bianco FJ, Scardino PT, Eastham JA. Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function (“trifecta”). Urology. 2005;66:83
  4. Catalona WJ, Carvalhal GF, Mager DE, Smith DS. Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies. J Urol. 1999;162:433
  5. Boorjian S, Cowan JE, Konety BR, DuChane J, Tewari A, Carroll PR, et al. Bladder cancer incidence and risk factors in men with prostate cancer: results from Cancer of the Prostate Strategic Urologic Research Endeavor. J Urol. 2007;177:883
  6. Shah SK, Lui PD, Baldwin DD, Ruckle HC. Urothelial carcinoma after external beam radiation therapy for prostate cancer. J Urol. 2006;175:2063
  7. Brenner DJ, Curtis RE, Hall EJ, Ron E. Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer. 2000;88:398
  8. Moon K, Stukenborg GJ, Keim J, Theodorescu D. Cancer incidence after localized therapy for prostate cancer. Cancer. 2006;107:991
  9. Neugut AI, Ahsan H, Robinson E, Ennis RD. Bladder carcinoma and other second malignancies after radiotherapy for prostate carcinoma. Cancer. 1997;79:1600
  10. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998;280:969
  11. Kupelian PA, Potters L, Khuntia D, Ciezki JP, Reddy CA, Reuther AM, et al. Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1–T2 prostate cancer. Int J Radiat Oncol Biol Phys. 2004;58:25
  12. Litwin MS, Gore JL, Kwan L, Brandeis JM, Lee SP, Withers HR, et al. Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer. Cancer. 2007;109:2239
  13. Kundu SD, Roehl KA, Eggener SE, Antenor JA, Han M, Catalona WJ. Potency, continence and complications in 3,477 consecutive radical retropubic prostatectomies. J Urol. 2004;172:2227
  14. Hu JC, Gold KF, Pashos CL, Mehta SS, Litwin MS. Role of surgeon volume in radical prostatectomy outcomes. J Clin Oncol. 2003;21:401
  15. Vickers AJ, Bianco FJ, Serio AM, Eastham JA, Schrag D, Klein EA, et al. The surgical learning curve for prostate cancer control after radical prostatectomy. J Natl Cancer Inst. 2007;99:1171
  16. Zeegers MP, Goldbohm RA, van denBrandt PA. A prospective study on active and environmental tobacco smoking and bladder cancer risk (The Netherlands). Cancer Causes Control. 2002;13:83
  17. Kry SF, Salehpour M, Followill DS, Stovall M, Kuban DA, White RA, et al. The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2005;62:1195

PII: S0022-5347(08)01841-7

doi: 10.1016/j.juro.2008.07.038

The Journal of Urology
Volume 180, Issue 5 , Pages 2005-2010 , November 2008

Article Tools